Ipca Labs profit leaps over 3-folds to Rs 445.68 crore in Q1
Advertisement
New Delhi: Drug firm Ipca Laboratories on Monday reported over three-fold jump in its consolidated net profit to Rs 445.68 crore for the quarter ended June due to robust sales.
The company had posted a net profit of Rs 129.43 crore for the corresponding period of the previous fiscal, Ipca Labs said in a BSE filing.
Consolidated total income stood at Rs 1,546.49 crore for the quarter under consideration. It was Rs 1,098.53 crore in the same period year ago, it added.
Shares of Ipca Laboratories closed at Rs 2,099.60 per unit on BSE, up 7.36 per cent over the previous close.
Read also: Divi's Labs Profit Up 80.61 Percent To Rs 492.06 Crore In Q1
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.